FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8246111000001107: Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
29121101000001117 Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
47211301000001118 Raptiva 125mg powder and solvent for solution for injection vials (Merck Serono Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Is a Efalizumab 125mg powder and solvent for solution for injection vials 1 vial true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Is pack of Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has active ingredient Efalizumab false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has AMP Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has specific active ingredient Efalizumab true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start